Skip Nav Destination
A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing
Cancer Epidemiol Biomarkers Prev (2022) 31 (1): 38–44.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Hormuzd A Katki
- Philip C Prorok
- Philip E Castle
- Lori M Minasian
- Paul F Pinsky
JNCI: Journal of the National Cancer Institute (2024) 116 (10): 1675.
- Jane M. Lange
- Kemal Caglar Gogebakan
- Roman Gulati
- Ruth Etzioni
Cancer Epidemiology, Biomarkers & Prevention (2024) 33 (6): 830.
- Diedron Lewis
- William W. L. Wong
- Joseph Lipscomb
- Susan Horton
PharmacoEconomics (2024) 42 (4): 393.
- Ronald E. Myers
- Mie H. Hallman
- Ayako Shimada
- Melissa A. DiCarlo
- Kaitlyn V. Davis
- William T. Leach
- Christopher V. Chambers
Cancer Medicine (2024) 13 (10)
- Hormuzd A Katki
- Philip C Prorok
- Philip E Castle
- Lori M Minasian
- Paul F Pinsky
JNCI: Journal of the National Cancer Institute (2024) 116 (8): 1280.
- Tiago Brito-Rocha
- Vera Constâncio
- Rui Henrique
- Carmen Jerónimo
Cells (2023) 12 (6): 935.
- Lance Baldo
- Richard Bourgon
- Charles K. Ackerman
Advances in Molecular Pathology (2023) 6 (1): 161.
- Marina Hanna
- Neelendu Dey
- William M. Grady
Clinical Gastroenterology and Hepatology (2023) 21 (13): 3465.
- Stephen W. Duffy
- Peter Sasieni
Cancer Epidemiology, Biomarkers & Prevention (2022) 31 (1): 3.
- Stefan Holdenrieder
- Vida Ungerer
- Angela Oberhofer
- Abel Jacobus Bronkhorst
Journal of Laboratory Medicine (2022) 46 (4): 247.
- Lincoln Nadauld
- Dana P Goldman
Future Oncology (2022) 18 (28): 3119.
- Nicolas Constantin
- Abu Ali Ibn Sina
- Darren Korbie
- Matt Trau
Epigenomes (2022) 6 (1): 6.
RSS Feeds